Mycoplasma bovis immunogenic lipoprotein MbovP739 function as an inflammatory stimulating factor

Jiating Ma1, Shujuan Wang2, Doukun Lu2

  • 1Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western China, Ningxia University, Yinchuan, 750021, China; School of Life Sciences, Ningxia University, Yinchuan, 750021, China.

Microbial Pathogenesis
|January 1, 2026
PubMed

Insights

Mycoplasma bovis lipoproteins are key to its survival. This study identified MbovP739 as a potent stimulator of pro-inflammatory cytokines, highlighting its role in bovine respiratory disease pathogenesis.

Area of Science:

  • Veterinary Immunology
  • Bacterial Pathogenesis
  • Molecular Biology

Background:

  • Mycoplasma bovis causes significant bovine respiratory disease globally.
  • Lipoproteins are crucial membrane components in Mycoplasma bovis, involved in nutrient acquisition, immune response induction, and adherence.
  • Understanding lipoprotein function is vital for controlling M. bovis infections.

Purpose of the Study:

  • To evaluate the immunogenicity of nine Mycoplasma bovis lipoproteins.
  • To determine the capacity of immunogenic lipoproteins to induce pro-inflammatory cytokine expression.
  • To elucidate the molecular mechanisms underlying the immune response to specific lipoproteins.

Main Methods:

  • Screening of nine Mycoplasma bovis lipoproteins for immunogenicity.
  • Assessment of pro-inflammatory cytokine induction in RAW264.7 macrophage cells.
  • RNA-sequencing analysis of bovine macrophages (BoMac cells) stimulated with identified lipoproteins.
  • Analysis of activated signaling pathways (IL-17 and TNF) in BoMac cells.

Main Results:

  • Three lipoproteins (MbovP468, MbovP537, MbovP739) exhibited higher immunogenicity.
  • These lipoproteins induced significantly greater pro-inflammatory cytokine production in RAW264.7 cells.
  • MbovP739 strongly induced an immune response in BoMac cells, upregulating chemokines and cytokines.
  • The IL-17 and TNF signaling pathways were notably activated by MbovP739 in BoMac cells.

Conclusions:

  • The Mycoplasma bovis lipoprotein MbovP739 demonstrates significant immunogenicity.
  • MbovP739 acts as a potent inflammatory stimulating factor, driving pro-inflammatory cytokine expression.
  • These findings identify MbovP739 as a potential target for therapeutic or diagnostic strategies against Mycoplasma bovis infections.